InterVenn Biosciences: John Leite
John Leite has become chief business officer at InterVenn Biosciences, based in South San Francisco. Previously, he was VP of oncology, market development, and product marketing for Illumina's oncology business. Prior to that, he was VP of commercial strategy and market access for Genoptix, and earlier in his career, he was a scientist at Invitrogen. Leite holds a PhD in biochemistry from the University of Pittburgh School of Medicine.